AIG
OTLK icon

American International Group’s Outlook Therapeutics OTLK Stock Holding History

American International Group’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,873
Closed -$46.2K – 1901
2024
Q1 		$46.2K Sell
3,873
-36
-0.9% -$291 ﹤0.01% 2804
2023
Q4 		$30.8K Buy
3,909
+38
+1% +$321 ﹤0.01% 2908
2023
Q3 		$17.1K Buy
3,871
+138
+4% +$3.05K ﹤0.01% 2997
2023
Q2 		$130K Buy
3,733
+1
+0% +$27 ﹤0.01% 2422
2023
Q1 		$81.4K Buy
3,732
+930
+33% +$20.8K ﹤0.01% 2546
2022
Q4 		$60.5K Sell
2,802
-10
-0.4% -$218 ﹤0.01% 2691
2022
Q3 		$69K Buy
2,812
+40
+1% +$930 ﹤0.01% 2718
2022
Q2 		$57K Sell
2,772
-56
-2% -$1.61K ﹤0.01% 2833
2022
Q1 		$101K Buy
2,828
+462
+20% +$14.4K ﹤0.01% 2594
2021
Q4 		$64K Sell
2,366
-71
-3% -$2.53K ﹤0.01% 2879
2021
Q3 		$106K Sell
2,437
-17
-0.7% -$820 ﹤0.01% 2781
2021
Q2 		$122 Buy
+2,454
New +$114K ﹤0.01% 2800

Other funds holding OTLK

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

American International Group's OTLK Position: Q2 2024 in Review

American International Group sold out of Outlook Therapeutics (OTLK) in Q2 2024, closing a stake of 3,873 shares — an estimated $46.2K sold.

American International Group first reported a position in OTLK in Q2 2021 and held it in 12 quarters. The position peaked at $130K in Q2 2023. 64 funds tracked by Wall St. Rank hold OTLK as of Q2 2024.

  • American International Group reported no remaining Outlook Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 3,873 Outlook Therapeutics shares in Q2 2024, an estimated $46.2K.
  • American International Group first reported a position in Outlook Therapeutics in Q2 2021 and held it in 12 quarters.
  • American International Group's Outlook Therapeutics position peaked at $130K in Q2 2023.
  • 64 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.